Introductie Myofunctionele Orthodontie Deel II - Nederlands
Wed, August 18 2021 - Wed, August 18 2021Opgenomen virtueel evenement
Introductie Myofunctionele Orthodontie Deel II - Nederlands
Deze cursus behandelt de volgende onderwerpen:
1. Introductie Myofunctionele Orthodontie
2. Myofunctionele Orthodontische Evaluatie (MOE)
3. Casussen (De beste om te starten)
4. Myobrace Activititeiten
5. Hoe te starten & Myobrace Educator
6. Vraag & Antwoord
LET OP: Deze webinar is een vervolg op de eerder opgenomen ‘Introductie Myofunctionele Orthodontie’. Daarom raden wij ten zeerste aan om eerst deel I te kijken voordat u aansluit bij ‘Introductie Myofunctionele Orthodontie Deel II'.
REGISTREREN
Hieronder vindt u de sessie voor dit webinar. Open de link hieronder en schrijf u in voor de opgenomen stream.
Opname - https://attendee.gotowebinar.com/register/5868159944038355983?source=website
18 augustus 14:00 uur - 16:30 uur Central European Standard Time (CEST)
Key Presenters
Niels Hulsink
Int. Sales & Product Manager MRC Europe, The Netherlands
Niels Hulsink has been working at MRC’s European Head Office since 2004. Prior to joining MRC Europe, he held various positions in the orthodontic field. Niels Hulsink is the lead lecturer for the European region and provides treatment support, education and advice to dental and orthodontic specialists and their teams across multiple countries in implementing myofunctional orthodontic treatments for both children and adults. His training focuses on the use of MRC’s treatment systems, including Myobrace®, Myosa®, Myoretainr® and Myotalea®, and the use of MRC Activities programs.
Niels van der Valk
MRC Educator/Training & Support, MRC Europe
Niels van der Valk joined Myofunctional Research Co. Europe in 2013. As a Myobrace® Educator, he supports dental and orthodontic specialists and their teams across various countries in implementing Myofunctional Orthodontic treatments. He delivers lectures, introductory and advanced courses and conducts in-house training sessions for practitioners and staff. His training focuses on the implementation of MRC’s treatment systems for both children and adults, including Myobrace®, Myosa®, Myoretainr® and Myotalea®.